Process and Results of Implementing Disease Management Program in Patients with First-time Ischemic Stroke

Overview

Journal Iran J Public Health

Date 2018 Sep 6

PMID 30182000

Citations 3

Authors

Hong-Rong Yang

Lei Ma

Yi-Feng Jiang

Yun-Cheng Wu

Eugene C Lai

Yan-Hong Zhu

Affiliations

Soon will be listed here.

Abstract

Background: This study aimed to examine the effect of disease management program (DMP) on the patients with first-time ischemic stroke (IS).

Methods: A DMP with 4 parts of performance indicators (PIs, including outpatient, emergency department, inpatient and follow-up treatment) was implemented in patients with stroke in 2 hospitals (Hospital T and R) in Shanghai China from 2007-2010. The effect of DMP on the outcome of IS patients was analyzed according to the criteria of the National Institute of Health Stroke Scale (NIHSS). Furthermore, the total effective rate of DMP, average length of stay, hospitalization cost, and cost-effectiveness ratio (CER) between DMP and non-DMP patients were calculated, followed by the cost-effectiveness analysis.

Results: The total effective rate of DMP (T: 69.9%; R: 76.6%) was significantly (<0.05) higher than that of non-DMP (T: 60.8%; R: 62.7%) group in the same hospital. In addition, a significant (<0.05) difference in effective rate was observed between DMP and non-DMP at the NIHSS score ≥ 7. Furthermore, the average length of stay and hospitalization cost of the patients in DMP group were significantly (<0.05) lower than those in non-DMP group. A superior CER was also found in DMP group than non-DMP group.

Conclusion: The implementation of DMP for IS can effectively improve the treatment outcome and reduce the average length of stay and hospitalization cost.

Citing Articles

A systematic review of the cost-effectiveness of emergency interventions for stroke in low- and middle-income countries.

Barbosa E, Gulela B, Taimo M, Lopes D, Offorjebe O, Risko N Afr J Emerg Med. 2020; 10(Suppl 1):S90-S94.

PMID: 33318909 PMC: 7723908. DOI: 10.1016/j.afjem.2020.05.009.

Cost-effectiveness of emergency care interventions in low and middle-income countries: a systematic review.

Werner K, Risko N, Burkholder T, Munge K, Wallis L, Reynolds T Bull World Health Organ. 2020; 98(5):341-352.

PMID: 32514199 PMC: 7265944. DOI: 10.2471/BLT.19.241158.

Identifying Performance Outliers for Stroke Care Based on Composite Score of Process Indicators: an Observational Study in China.

Wang C, Su S, Li X, Li J, Bao X, Liu M J Gen Intern Med. 2020; 35(9):2621-2628.

PMID: 32462572 PMC: 7459034. DOI: 10.1007/s11606-020-05923-x.

References

Knox D, Mischke L . Implementing a congestive heart failure disease management program to decrease length of stay and cost. J Cardiovasc Nurs. 1999; 14(1):55-74. DOI: 10.1097/00005082-199910000-00007. View

Krumholz H, Amatruda J, Smith G, Mattera J, Roumanis S, Radford M . Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. J Am Coll Cardiol. 2002; 39(1):83-9. DOI: 10.1016/s0735-1097(01)01699-0. View

Lyden P, Lu M, Levine S, Brott T, Broderick J . A modified National Institutes of Health Stroke Scale for use in stroke clinical trials: preliminary reliability and validity. Stroke. 2001; 32(6):1310-7. DOI: 10.1161/01.str.32.6.1310. View

Adams H, Adams R, Del Zoppo G, Goldstein L . Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke. 2005; 36(4):916-23. DOI: 10.1161/01.STR.0000163257.66207.2d. View

Adams Jr H, Brott T, Furlan A, Gomez C, Grotta J, Helgason C . Guidelines for Thrombolytic Therapy for Acute Stroke: a Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American.... Stroke. 1996; 27(9):1711-8. View

Gandjour A . A model to predict the cost-effectiveness of disease management programs. Health Econ. 2009; 19(6):697-715. DOI: 10.1002/hec.1503. View

Gladstone D, Rodan L, Sahlas D, Lee L, Murray B, Ween J . A citywide prehospital protocol increases access to stroke thrombolysis in Toronto. Stroke. 2009; 40(12):3841-4. DOI: 10.1161/STROKEAHA.108.540377. View

Jia Q, Liu L, Wang Y . Stroke in China. Clin Exp Pharmacol Physiol. 2009; 37(2):259-64. DOI: 10.1111/j.1440-1681.2009.05290.x. View

Sidorov J, Shull R, Tomcavage J, Girolami S, Lawton N, Harris R . Does diabetes disease management save money and improve outcomes? A report of simultaneous short-term savings and quality improvement associated with a health maintenance organization-sponsored disease management program among patients fulfilling.... Diabetes Care. 2002; 25(4):684-9. DOI: 10.2337/diacare.25.4.684. View

10.

Lorig K, Sobel D, Stewart A, BROWN Jr B, Bandura A, Ritter P . Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: a randomized trial. Med Care. 1999; 37(1):5-14. DOI: 10.1097/00005650-199901000-00003. View

11.

Jaarsma T, van der Wal M, Lesman-Leegte I, Luttik M, Hogenhuis J, Veeger N . Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH). Arch Intern Med. 2008; 168(3):316-24. DOI: 10.1001/archinternmed.2007.83. View

12.

Schafer I, Kuver C, Gedrose B, Hoffmann F, Russ-Thiel B, Brose H . The disease management program for type 2 diabetes in Germany enhances process quality of diabetes care - a follow-up survey of patient's experiences. BMC Health Serv Res. 2010; 10:55. PMC: 2843701. DOI: 10.1186/1472-6963-10-55. View

13.

LaBresh K, Reeves M, Frankel M, Albright D, Schwamm L . Hospital treatment of patients with ischemic stroke or transient ischemic attack using the "Get With The Guidelines" program. Arch Intern Med. 2008; 168(4):411-7. DOI: 10.1001/archinternmed.2007.101. View

14.

Hollenbeak C, Boltz M, Wang L, Schubart J, Ortenzi G, Zhu J . Cost-effectiveness of the National Surgical Quality Improvement Program. Ann Surg. 2011; 254(4):619-24. DOI: 10.1097/sla.0b013e318230010a. View

15.

Badamgarav E, Weingarten S, Henning J, Knight K, Hasselblad V, Gano Jr A . Effectiveness of disease management programs in depression: a systematic review. Am J Psychiatry. 2003; 160(12):2080-90. DOI: 10.1176/appi.ajp.160.12.2080. View

16.

Joshi M, Bernard D . Clinical performance improvement series. Classic CQI integrated with comprehensive disease management as a model for performance improvement. Jt Comm J Qual Improv. 1999; 25(8):383-95. DOI: 10.1016/s1070-3241(16)30453-9. View

17.

Lorig K, Sobel D, Ritter P, Laurent D, Hobbs M . Effect of a self-management program on patients with chronic disease. Eff Clin Pract. 2002; 4(6):256-62. View

18.

Doan Q, Gillard P, Brashear A, Halperin M, Hayward E, Varon S . Cost-effectiveness of onabotulinumtoxinA for the treatment of wrist and hand disability due to upper-limb post-stroke spasticity in Scotland. Eur J Neurol. 2013; 20(5):773-80. DOI: 10.1111/ene.12062. View

19.

Gravely S, Reid R, Oh P, Ross H, Stewart D, Grace S . A prospective examination of disease management program use by complex cardiac outpatients. Can J Cardiol. 2012; 28(4):490-6. DOI: 10.1016/j.cjca.2012.01.004. View

20.

Galbreath A, Krasuski R, Smith B, Stajduhar K, Kwan M, Ellis R . Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure. Circulation. 2004; 110(23):3518-26. DOI: 10.1161/01.CIR.0000148957.62328.89. View